'This drug will be very helpful to people who want to lose weight, need to lose weight, very important for the economy so people can get back into work,' said Labour Party leader Keir Starmer, stressing the potential economic benefits of weight loss treatments.
'Illness caused by obesity causes people to take an extra four sick days a year on average, while many others are forced out of work altogether,' explained Health Secretary Wes Streeting, linking health issues to workforce participation.
'The long-term benefits of these drugs could be monumental in our approach to tackling obesity. For many people, these weight-loss jabs will be life-changing, help them get back to work, and ease the demands on our NHS.' This reflects a hopeful outlook on the societal impact of weight-loss treatments.
The government's five-year trial of the weight loss drug Mounjaro on 3,000 participants aims to investigate its effect on reducing unemployment and the burden on public health services.
Collection
[
|
...
]